49 related articles for article (PubMed ID: 1966730)
1. Evidence for a role of serotonin in initiation of coronary arterial thrombosis in dog and man.
Noble MI; Drake-Holland AJ
Clin Physiol Biochem; 1990; 8 Suppl 3():50-5. PubMed ID: 1966730
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of acute platelet thrombosis formation in stenosed canine coronary arteries by specific serotonin 5HT2 receptor antagonist ritanserin.
Torr S; Noble MI; Folts JD
Cardiovasc Res; 1990 Jun; 24(6):465-70. PubMed ID: 2117499
[TBL] [Abstract][Full Text] [Related]
3. The possible role of serotonin 5HT2 receptor antagonism in cardioprotection.
Noble MI; Drake-Holland AJ
Neth J Med; 1992 Oct; 41(3-4):183-9. PubMed ID: 1470290
[No Abstract] [Full Text] [Related]
4. The role of serotonin in thrombogenesis.
De Clerck F
Clin Physiol Biochem; 1990; 8 Suppl 3():40-9. PubMed ID: 1966729
[TBL] [Abstract][Full Text] [Related]
5. The alpha-adrenergic receptor blocking effect of ketanserin and the interaction between alpha-adrenergic and S2-serotonergic receptor blockade.
van der Starre PJ; Reneman RS
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S54-61. PubMed ID: 2459516
[TBL] [Abstract][Full Text] [Related]
6. Insights into the role of thromboxane A2 and serotonin in the pathogenesis of unstable angina.
Machado AP; Saavedra JA; Ribeiro C
Rev Port Cardiol; 1994 Dec; 13(12):935-46, 893. PubMed ID: 7873224
[TBL] [Abstract][Full Text] [Related]
7. Are there interactions between S2-serotonergic and alpha 1-adrenergic receptors in isolated canine arteries?
Lüscher TF; Vanhoutte PM
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S16-21. PubMed ID: 2459508
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
9. Effects of 3-methoxycyproheptadine in a canine model of coronary thrombosis.
Bush LR; Remy DC
J Pharmacol Exp Ther; 1988 Nov; 247(2):796-802. PubMed ID: 3183974
[TBL] [Abstract][Full Text] [Related]
10. Effects of the serotonin antagonists, cyproheptadine, ketanserin and mianserin, on cyclic flow reductions in stenosed canine coronary arteries.
Bush LR
J Pharmacol Exp Ther; 1987 Feb; 240(2):674-82. PubMed ID: 3806419
[TBL] [Abstract][Full Text] [Related]
11. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
Salvati P; Dho L; Ukmar G; Vaga L; Rimoldi O; Patrono C
J Pharmacol Exp Ther; 1994 Apr; 269(1):238-45. PubMed ID: 8169831
[TBL] [Abstract][Full Text] [Related]
12. Role of serotonin, histamine, and thromboxane A2 in platelet-induced contractions of coronary arteries and aortae from rabbits.
Awano K; Yokoyama M; Fukuzaki H
J Cardiovasc Pharmacol; 1989 May; 13(5):781-92. PubMed ID: 2472528
[TBL] [Abstract][Full Text] [Related]
13. Antagonism by methysergide of neurogenic vasoconstriction in the dog forelimb.
Jandhyala BS; Kivlighn SD
Fed Proc; 1987 Feb; 46(2):276-80. PubMed ID: 3100343
[TBL] [Abstract][Full Text] [Related]
14. Dispersion of coronary artery thrombi by antagonism of platelet serotonin receptor in the dog.
Belcher PR; Drake-Holland AJ; Hynd J; Noble MI
Cardiovasc Res; 1992 Mar; 26(3):292-6. PubMed ID: 1423425
[TBL] [Abstract][Full Text] [Related]
15. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
Cohen ML; Schenck KW; Kurz KD
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
[TBL] [Abstract][Full Text] [Related]
16. Sildenafil improves coronary artery patency in a canine model of platelet-mediated cyclic coronary occlusion after thrombolysis.
Lewis GD; Witzke C; Colon-Hernandez P; Guerrero JL; Bloch KD; Semigran MJ
J Am Coll Cardiol; 2006 Apr; 47(7):1471-7. PubMed ID: 16580539
[TBL] [Abstract][Full Text] [Related]
17. Contractions of isolated canine coronary arteries resistant to S2-serotonergic blockade.
Cohen RA
J Pharmacol Exp Ther; 1986 May; 237(2):548-52. PubMed ID: 2939235
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous distribution of adrenergic receptors in coronary arteries and their influence on coronary arterial tone.
Turlapaty PD; Altura BM
Microcirc Endothelium Lymphatics; 1985; 2(6):617-42. PubMed ID: 3016491
[TBL] [Abstract][Full Text] [Related]
19. Influence of selective endoperoxide/thromboxane A2 receptor antagonism with sulotroban on lysis time and reocclusion rate after tissue plasminogen activator-induced coronary thrombolysis in the dog.
Shebuski RJ; Smith JM; Storer BL; Granett JR; Bugelski PJ
J Pharmacol Exp Ther; 1988 Aug; 246(2):790-6. PubMed ID: 3136245
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by the combined Ca2+ and 5-HT2 receptor antagonist nexopamil (LU 49938) of intracoronary thrombus formation in a canine model of arterial stenosis and intimal damage.
Kirchengast M; Rübsamen K; Lehmann HD
J Cardiovasc Pharmacol; 1993 Nov; 22(5):687-94. PubMed ID: 7506319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
